Ertaczo Topical Cream 2pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Ertaczo: Topical cream (2%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Ertaczo 2% Topical Cream

What is this Medicine?

SERTACONAZOLE (ser ta KON na zole) is an antifungal medicine. It is used to treat certain kinds of fungal or yeast infections of the skin.

CVS Pharmacy Patient Statistics for Ertaczo: Topical cream(2%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Ertaczo 2% Topical Cream

NDC: 001875115
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Tinea Pedis

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Ertaczo 2% Topical Cream

Reported Side Effects for Ertaczo 2% Topical Cream

Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Skin Redness Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Darkened Skin Patches Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Vesicular Rash Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Allergic Skin Reaction Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Dry Skin Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Skin Irritation Incidence:
2.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ertaczo

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5